A Kentucky man's cancer treatment was denied by his health insurer, despite recommendations from leading cancer centers. The insurer deemed the treatment 'experimental' and 'unproven,' even though it's a standard procedure at MD Anderson Cancer Center.
Angela Pike’s husband, Tracy, had just celebrated his 45th birthday when he was diagnosed with Stage 4 stomach cancer. A father of three and the maintenance chief of a Louisville, Kentucky, skyscraper, Pike immediately started chemotherapy, which reduced the size of the tumor his doctor had discovered.
While continuing the chemotherapy would keep him going in the short term, Pike’s best shot at a longer and more healthy life, his doctor told him and his wife, was to undergo a routinely practiced treatment combining surgery and intensive chemotherapy at the MD Anderson Cancer Center in Houston. After MD Anderson agreed to provide Pike with the treatment, he and his family traveled to Texas in 2023. The night before the first procedure, Pike’s surgeon called to let the family know Blue Cross and Blue Shield of Illinois, Pike’s health insurer through his employer, had declined to cover the roughly $40,000 treatment. The insurer ruled Pike’s treatment was “not medically necessary” because it was “experimental, investigational and unproven,” documents show. But this is not the view of the National Comprehensive Cancer Network, a not-for-profit alliance of leading cancer centers, in its widely followed cancer treatment guidelines. The network’s guidelines recommend the procedure Pike sought for “a select group of patients after multidisciplinary evaluation and discussion as well as appropriate clinical context.” The denial was a temporary setback, Angela Pike figured. “The surgeon at MD Anderson thought it would be an easy appeal,” she said. “We were being told he may have it any day now.” But despite repeated arguments from the MD Anderson surgeon who said the procedure could save Tracy Pike’s life, Blue Cross and Blue Shield of Illinois continued to reject the treatment. Angela said the last straw came when she learned that one of the insurer’s physicians who had rejected the treatment was not a cancer doctor at all. He was an obstetrician-gynecologist
HEALTH INSURANCE CANCER TREATMENT DENIAL EXPERIMENTAL MD ANDERSON
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Girl Flooded With Donations After Insurer Denies Prosthetic Arm Pays It ForwardAfter a private company offered to cover the cost of her robotic arm, her family redirected donations to help a boy in Maryland also in need of one.
Read more »
Health Insurer Scraps Widely Hated Plan to Cap Anesthesia CoverageThe plan for 2025 resurfaced after the fatal shooting of UnitedHealthcare CEO Brian Thompson on Wednesday in Manhattan.
Read more »
Health insurer reverses course on anesthesia policy after receiving backlashAnthem Blue Cross Blue Shield backtracked on imposing a anesthesia policy change in multiple states after the health insurer received strong backlash.
Read more »
Health Insurer Reverses Controversial Anesthesia Payment PolicyAnthem Blue Cross Blue Shield reversed its decision to tie payments for anesthesia services to the length of time a patient was under anesthesia, following widespread misinformation and public outcry. The insurer emphasized that the policy change was meant to clarify appropriateness of anesthesia services based on clinical guidelines.
Read more »
Health Insurer Reverses Controversial Anesthesia PolicyAnthem Blue Cross Blue Shield reverses a controversial policy change following public outcry, clarifying that it never intended to deny medically necessary anesthesia services. The original policy aimed to clarify the appropriateness of anesthesia services but was met with widespread opposition.
Read more »
Health insurer stocks fall as WSJ says lawmakers set to break up pharmacy-benefit managersHealth insurer stocks fall as WSJ says lawmakers set to break up pharmacy-benefit managers
Read more »